Combined resources will improve cardiovascular-kidney-metabolic care

DALLAS and KANSAS CITY — The American Heart Association, devoted to changing the future to a world of healthier lives for all, has acquired program assets of the Cardiometabolic Center Alliance (CMCA) collaborative, strengthening the efforts of both organizations to establish integrated care that holistically manages cardiovascular, kidney, and metabolic health.

The missions of the CMCA and American Heart Association are closely aligned, focusing on comprehensive risk reduction and improving the quality of care and outcomes of patients with cardiometabolic disease. In addition, they both aim to accomplish these goals by supporting a patient-centered, team-based approach.

Founded by Saint Luke’s Mid America Heart Institute in Kansas City, Mo., under the medical direction of Mikhail Kosiborod, M.D., the CMCA began as a bold initiative to reshape cardiometabolic care. The CMCA was established through the Saint Luke’s Michael and Marlys Haverty Cardiometabolic Center of Excellence, which designed and successfully implemented a novel approach to treating Type 2 diabetes, pre-diabetes, and related cardiovascular conditions together — rather than addressing conditions or risk factors separately — providing team-based, comprehensive care specifically tailored to each patient.